Aptorum Group Ltd - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
APM Nasdaq 2834 http://www.aptorumgroup.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Aptorum Group Ltd

Here's What Aptorum Group Limited's (NASDAQ:APM) Shareholder Ownership Structure Looks Like - Jul 3rd, 2020 4:56 pm
Analysts Recommend Catching These 2 Falling Knives - Jun 25th, 2020 3:25 pm
Aptorum Group Limited Strengthens Its Presence in the US With the Appointment of Dr. Kira Sheinerman - Jun 15th, 2020 12:00 pm
Aptorum Group Limited to Present at the Infectious Disease Virtual Conference - Apr 29th, 2020 12:00 pm
Aptorum Group Limited Reports 2019 Fiscal Year End Financial Results and Provides Business Update - Apr 29th, 2020 12:00 pm
Aptorum Group Limited to Present at the Planet MicroCap Showcase Virtual Investor Conference 2020 - Apr 15th, 2020 12:00 pm
Aptorum Group Collaborates with Covar Pharmaceuticals To Investigate at Least 3 Repurposed Drug Candidates (SACT-COV19) for Coronavirus Disease 2019 (COVID-19) under Existing Smart-ACT™ Platform and Acticule Infectious Disease Platform - Mar 30th, 2020 12:00 pm
Aptorum Group Limited Corporate Update and To Hold Q1 2020 Investor Update Call To Discuss Recent Development and Pipeline Progress - Mar 30th, 2020 12:00 pm
Aptorum Group Limited to Present at the Solebury Trout Virtual Investor Conference - Mar 30th, 2020 12:00 pm
Solebury Trout Announces Virtual Conference Series with Presentations from Life Science Companies - Mar 24th, 2020 8:00 pm
Did You Manage To Avoid Aptorum Group's (NASDAQ:APM) 13% Share Price Drop? - Jan 3rd, 2020 10:38 am
Aptorum Group Limited's (NASDAQ:APM) Single Biggest Risk For Investors - Sep 19th, 2019 12:10 pm